Formosa Laboratories is a global API supplier. We provides GMP one-stop-shop CDMO services. The services ranges from small-molecule and polymer API to in-house payload-linker CMC services and antibody bio-conjugation for Antibody Drug Conjugate (ADC). We also offer aseptic liquid filling and lyophilization of both cytotoxic and non-cytotoxic injectables.
|2021||Passed GMP inspection by TFDA for packaging and labeling of medicinal products. Passed GDP inspection by TFDA for medicinal products.|
|2018||Formosa’s customer in mainland China get the 1st Montelukast GQCE approval in Chinese mainland.|
|2013||Passed joint GMP inspection by EDQM and BGC Hamburg|
|2010||Passed 1st PAI for Mycophenolate Mofetil by COFEPRIS of Mexico|
|2009||Passed 1st PAI for Gadodiamide by PMDA of Japan|
|2007||Passed 1st GMP inspection by BSG of Hamburg, Germany|
|2004||Passed 1st PAI by US FDA for Leflunomide API|